Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Issue: Jul/Aug 2023 - Volume 27, Number 4
View All Articles in Issue
Page(s): 340-346
Download in electronic PDF format for $75
Abstract: Microsponges are porous cross-linked polymers, which have the ability to load a wide range of pharmaceutical active ingredients. They are used topically for long-term treatment applications in addition to the oral route of administration. They are characterized by the efficient distribution of active ingredients, which are loaded at a low quantity to release the drug over longer periods of time by altering the release characteristics. The objective of this study was to develop a novel drug-delivery system that included ramipril microsponges. Ramipril is an antihypertensive drug used in the treatment of elevated blood pressure. It has about 28% oral bioavailability and is eliminated through the kidneys. When administered in an instant dosage form, this medicine produces several side effects, including postural hypotension, hyperkalemia, and angioedema. Included in this study were six distinct formulas of microsponges containing ramipril and Eudragit L 100 at varied ratios that were prepared by using the Quasi-emulsion solvent diffusion technique to avoid side effects. The particle size and physical characteristics of these formulations were investigated. The effects of the polymer/drug ratio on the physical features of a microsponge’s physical and compatibility study was performed by using the Fourier transform infrared spectroscopy, differential scanning calorimetry, loading efficiency, surface morphology, and particle sizes. In addition, an in vitro drug-release profile was conducted. The physical characterization showed that the loading efficiency and production yield were both improved for microsponge formulation F1. In vitro dissolution studies were performed on all formulations, and the findings were analyzed kinetically, revealing that the ramipril release rate was altered in all formulations. This study offers a new medication delivery method based on microsponge technology.
Related Keywords:
Hassanien Sagban Taghi, PhD in Pharmacy, Mustafa R. Abdulbaqi, PhD in Pharmacy, Laith Hamza Samein, PhD in Pharmacy, Maha H. Philip Rahmani, MSc in Pharmacy, ramipril, microsponges, drug delivery system, extended drug release, topical preparation, microsponge formulations, quasi-emulsion solvent diffusion technique, microsphere-based polymers, hypertension, antihypertensive agent, high blood pressure, angiotensin-converting enzyme inhibitor, ACE inhibitor
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
|
Jul/Aug 2023
Pg. 340-346
|
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time
Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
|
Sep/Oct 2012
Pg. 431-433
|
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 7-16
|
Art of Pharmacy v. State
Standridge Rob
|
May/Jun 2022
Pg. 182-186
|
PreScription: Compounding Pharmacy Issues for 2017
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 4
|
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
|
Mar/Apr 2017
Pg. 95-102
|
The BPS Pharmacy Specialty Certification Program
Bertin Richard J
|
May/Jun 1999
Pg. 200-203
|
Regulatory and Operational Issues of Founding a Compounding Pharmacy
Smith Lisa K
|
Nov/Dec 2002
Pg. 434-437
|
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 449-450
|
Experimental Multidisciplinary Approach Based on Compounded Capsule's Quality Evaluation for Pharmacy Undergraduate Courses
dos Santos Matheus Skrcek Ribeiro, de Lima Amanda Muniz dos Santos, Christoff Adriana de Oliveira, Teixeira Mariana Lopes, Carneiro Jaqueline
|
Mar/Apr 2021
Pg. 104-108
|
Metro Atlanta Board - Certified Specialists' Attitudes Toward Compounding Pharmacy
Greenburg Aimee R, Barnett Candace W
|
Jan/Feb 2004
Pg. 65-72
|
Wish You Were Here: The History of Pharmacy Museum at the Arizona College of Pharmacy, Tucson, Arizona
Worthen Dennis B
|
Mar/Apr 2002
Pg. 116-117
|
Legal & Ethical Issues for Pharmacy Websites
King LD, Brashares Jennifer
|
Mar/Apr 2003
Pg. 88-92
|
Pharmacy History: Pharmacy Knots
Worthen Dennis B
|
May/Jun 2005
Pg. 220-221
|
PostScription: Innovative Community Pharmacy Practice: Past, Present, and Future
Huffman D C
|
Jul/Aug 2010
Pg. 350-351
|
PostScription: Profile of a Pharmacy Compounding Accreditation Board Accredited Pharmacy: Avera Doctors Plaza 2 Pharmacy
Hoffman Karen
|
Nov/Dec 2010
Pg. 531
|
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
|
Mar/Apr 2018
Pg. 108-121
|
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
|
Sep/Oct 2016
Pg. 367-374
|
Applying Quality of Design Concepts to Pharmacy Compounding
Timko Robert J
|
Nov/Dec 2015
Pg. 453-463
|
Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 356
|
Return to Top |